Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention

A Gradíssimo, RD Burk - Expert Review of Molecular Diagnostics, 2017 - Taylor & Francis
ABSTRACT Introduction: Human papillomavirus (HPV)-related cancers can be averted by
type-specific vaccination (primary prevention) and/or through detection and ablation of …

High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early …

K Torres-Poveda, I Ruiz-Fraga, V Madrid-Marina… - Bmc Cancer, 2019 - Springer
Background Cervical cancer is the second cause leading of malignancy-related death
among Mexican women. The present study determined the population-based prevalence of …

Self-partitioning SlipChip for slip-induced droplet formation and human papillomavirus viral load quantification with digital LAMP

Z Yu, W Lyu, M Yu, Q Wang, H Qu, RF Ismagilov… - Biosensors and …, 2020 - Elsevier
Human papillomavirus (HPV) is one of the most common sexually transmitted infections
worldwide, and persistent HPV infection can cause warts and even cancer. Nucleic acid …

[PDF][PDF] The Abbott RealTime High Risk HPV test is a clinically validated human papillomavirus assay for triage in the referral population and use in primary cervical …

M Poljak, A Ostrbenk - Acta Dermatovenerol Alp Pannonica …, 2013 - acta-apa.mf.uni-lj.si
Introduction: Human papillomavirus (HPV) testing has become an essential part of current
clinical practice in the management of cervical cancer and precancerous lesions. We …

Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening

M Rebolj, S Preisler, DM Ejegod, C Rygaard, E Lynge… - PLoS …, 2014 - journals.plos.org
We aimed to determine the disagreement in primary cervical screening between four human
papillomavirus assays: Hybrid Capture 2, cobas, CLART, and APTIMA. Material from 5,064 …

Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection

MJ Kwon, KH Roh, H Park, HY Woo - Journal of Clinical Virology, 2014 - Elsevier
Background Human papillomavirus (HPV) testing is an important part of cervical cancer
screening and management of women with abnormal cytology results. The Hybrid Capture 2 …

From human papillomavirus (HPV) detection to cervical cancer prevention in clinical practice

SH Lee, JS Vigliotti, VS Vigliotti, W Jones - Cancers, 2014 - mdpi.com
The newly gained knowledge of the viral etiology in cervical carcinogenesis has prompted
industrial interests in developing virology-based tools for cervical cancer prevention. Due to …

Characterization and diversity of 243 complete human papillomavirus genomes in cervical swabs using next generation sequencing

A Latsuzbaia, A Wienecke-Baldacchino, J Tapp… - Viruses, 2020 - mdpi.com
In recent years, next generation sequencing (NGS) technology has been widely used for the
discovery of novel human papillomavirus (HPV) genotypes, variant characterization and …

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex …

M Bell, B Verberckmoes, J Devolder… - Microbiology …, 2023 - Am Soc Microbiol
Infection with high-risk human papillomavirus (hrHPV) is well recognized as the main cause
of cervical cancer. The recently developed Seegene Allplex HPV28 assay is a novel …

A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX®) in female school students in Thailand

S Jiamsiri, C Rhee, HS Ahn, N Poudyal, HW Seo… - Plos one, 2022 - journals.plos.org
Human papillomavirus (HPV) is a common infection principally spread through sexual
activity. Most HPV infections are asymptomatic and resolve spontaneously. However …